Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01424696 · ClinicalTrials.gov registry record

Baby Observational and Nutritional Study

A clinical trial, sponsored by Seattle Children's Hospital.

Completed
Registry status
231
Enrollment target

NCT01424696 is a clinical trial that has completed, run by Seattle Children's Hospital. The registered enrollment target is 231 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01424696 has completed, sponsored by Seattle Children's Hospital.

COMPLETED
Registry status
231 participants
Enrollment target

Study Summary

Cystic fibrosis (CF) is a life-shortening disease that causes breathing and digestive problems, but can now be diagnosed at the time of birth. Lung function is very hard to measure in infants, but growth is not. In this study the investigators aim to define growth in infants with CF in the first year of life with research quality precision and to understand factors that interfere with good growth. Pancreatic enzyme replacement therapy (PERT) will be also be studied in a subgroup of infants. Two different doses of PERT will be evaluated for improving fat and nitrogen absorption in infants with CF.

Trial Details

FieldValue
Enrollment Target 231 participants
Start Date 2011-12
Est. Completion 2015-04

Sponsor

Seattle Children's Hospital

168 total trials

What the Registry Record Tells You About NCT01424696

The ClinicalTrials.gov registry entry for NCT01424696 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01424696 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01424696 about?

NCT01424696 is a clinical study titled "Baby Observational and Nutritional Study". Cystic fibrosis (CF) is a life-shortening disease that causes breathing and digestive problems, but can now be diagnosed at the time of birth. Lung function is very hard to measure in infants, but growth is not. In this study the investigators aim to define growth in infants with CF in the first yea...

What is the current status of trial NCT01424696?

This trial is currently completed. The enrollment target is 231 participants. The study started on 2011-12. Estimated completion is 2015-04.

Who is sponsoring clinical trial NCT01424696?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.